AG˹ٷ

STOCK TITAN

CBIZ Reports Second-Quarter 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

CBIZ (NYSE:CBZ) reported exceptional second-quarter 2025 results, with total revenue surging 62.7% to $683.5 million. The company's net income more than doubled, reaching $41.9 million, with GAAP EPS of $0.66, up 69.2%. Adjusted EBITDA showed remarkable growth of 127.9% to $117.2 million.

For the first six months of 2025, CBIZ achieved total revenue of $1.5 billion, representing a 66.4% increase. The company's performance was notably bolstered by the strategic Marcum acquisition, which management described as one of the most value-creating decisions in company history.

Looking ahead, CBIZ provided its 2025 outlook, projecting total revenue between $2.8-2.95 billion, with adjusted EPS expected in the range of $3.60-3.65 and adjusted EBITDA between $450-456 million.

CBIZ (NYSE:CBZ) ha riportato risultati eccezionali nel secondo trimestre del 2025, con un fatturato totale in crescita del 62,7% a 683,5 milioni di dollari. L'utile netto della società è più che raddoppiato, raggiungendo i 41,9 milioni di dollari, con un EPS GAAP di 0,66 dollari, in aumento del 69,2%. L'EBITDA rettificato ha mostrato una crescita notevole del 127,9%, arrivando a 117,2 milioni di dollari.

Nei primi sei mesi del 2025, CBIZ ha raggiunto un fatturato totale di 1,5 miliardi di dollari, con un aumento del 66,4%. Le performance dell'azienda sono state significativamente rafforzate dall'acquisizione strategica di Marcum, definita dal management come una delle decisioni più generatrici di valore nella storia della società.

Guardando al futuro, CBIZ ha fornito le previsioni per il 2025, stimando un fatturato totale tra 2,8 e 2,95 miliardi di dollari, con un EPS rettificato previsto tra 3,60 e 3,65 dollari e un EBITDA rettificato compreso tra 450 e 456 milioni di dollari.

CBIZ (NYSE:CBZ) reportó resultados excepcionales en el segundo trimestre de 2025, con ingresos totales que aumentaron un 62,7% hasta 683,5 millones de dólares. El ingreso neto de la compañía más que se duplicó, alcanzando los 41,9 millones de dólares, con un EPS GAAP de 0,66 dólares, un aumento del 69,2%. El EBITDA ajustado mostró un crecimiento notable del 127,9%, llegando a 117,2 millones de dólares.

En los primeros seis meses de 2025, CBIZ logró unos ingresos totales de 1,5 mil millones de dólares, lo que representa un aumento del 66,4%. El desempeño de la compañía se vio notablemente impulsado por la adquisición estratégica de Marcum, que la dirección describió como una de las decisiones que más valor han creado en la historia de la empresa.

De cara al futuro, CBIZ proporcionó sus perspectivas para 2025, proyectando unos ingresos totales entre 2,8 y 2,95 mil millones de dólares, con un EPS ajustado esperado en el rango de 3,60 a 3,65 y un EBITDA ajustado entre 450 y 456 millones de dólares.

CBIZ (NYSE:CBZ)� 2025� 2분기 뛰어� 실적� 보고했으�, 총수익이 62.7% 증가� 6� 8,350� 달러� 달했습니�. 회사� 순이익은 � � 이상 증가하여 4,190� 달러� 기록했으�, GAAP 주당순이�(EPS)은 0.66달러� 69.2% 상승했습니다. 조정 EBITDA� 127.9%� 놀라운 성장으로 1� 1,720� 달러� 달했습니�.

2025� 상반� 동안 CBIZ� 총수� 15� 달러� 달성하며 66.4% 증가했습니다. 경영진은 전략� 인수� Marcum� 회사 역사� 가� 가� 창출� � 결정 � 하나라고 평가했습니다.

앞으� CBIZ� 2025� 전망� 제시하며, 총수익을 28억~29� 5천만 달러� 예상하고, 조정 EPS� 3.60~3.65달러, 조정 EBITDA� 4� 5,000만~4� 5,600� 달러 사이가 � 것으� 전망했습니다.

CBIZ (NYSE:CBZ) a annoncé des résultats exceptionnels pour le deuxième trimestre 2025, avec un chiffre d'affaires total en hausse de 62,7 % à 683,5 millions de dollars. Le bénéfice net de la société a plus que doublé, atteignant 41,9 millions de dollars, avec un BPA GAAP de 0,66 $, en hausse de 69,2 %. L'EBITDA ajusté a connu une croissance remarquable de 127,9 % pour atteindre 117,2 millions de dollars.

Au cours des six premiers mois de 2025, CBIZ a réalisé un chiffre d'affaires total de 1,5 milliard de dollars, soit une augmentation de 66,4 %. La performance de la société a été particulièrement renforcée par l'acquisition stratégique de Marcum, que la direction a qualifiée de l'une des décisions les plus créatrices de valeur de l'histoire de l'entreprise.

Pour l'avenir, CBIZ a présenté ses perspectives pour 2025, prévoyant un chiffre d'affaires total compris entre 2,8 et 2,95 milliards de dollars, avec un BPA ajusté attendu dans une fourchette de 3,60 à 3,65 $ et un EBITDA ajusté entre 450 et 456 millions de dollars.

CBIZ (NYSE:CBZ) meldete herausragende Ergebnisse für das zweite Quartal 2025, mit einem Gesamtumsatz, der um 62,7 % auf 683,5 Millionen US-Dollar anstieg. Der Nettogewinn des Unternehmens verdoppelte sich mehr als und erreichte 41,9 Millionen US-Dollar, mit einem GAAP-Gewinn je Aktie (EPS) von 0,66 US-Dollar, ein Anstieg von 69,2 %. Das bereinigte EBITDA verzeichnete ein bemerkenswertes Wachstum von 127,9 % auf 117,2 Millionen US-Dollar.

Für die ersten sechs Monate des Jahres 2025 erzielte CBIZ einen Gesamtumsatz von 1,5 Milliarden US-Dollar, was einer Steigerung von 66,4 % entspricht. Die Leistung des Unternehmens wurde maßgeblich durch die strategische Übernahme von Marcum gestärkt, die vom Management als eine der wertschöpfendsten Entscheidungen in der Unternehmensgeschichte bezeichnet wurde.

Mit Blick auf die Zukunft gab CBIZ seine Prognose für 2025 bekannt und erwartet einen Gesamtumsatz zwischen 2,8 und 2,95 Milliarden US-Dollar, mit einem bereinigten EPS im Bereich von 3,60 bis 3,65 und einem bereinigten EBITDA zwischen 450 und 456 Millionen US-Dollar.

Positive
  • Revenue surged 62.7% year-over-year to $683.5M in Q2 2025
  • Net income more than doubled with 111.9% growth to $41.9M
  • Adjusted EBITDA showed exceptional growth of 127.9% to $117.2M
  • Strong client retention and robust free cash flow reported
  • Strategic Marcum acquisition delivering significant value
Negative
  • Higher effective tax rate expected at approximately 29%
  • Challenging market conditions acknowledged by management

Insights

CBIZ delivered exceptional Q2 2025 results with substantial revenue and profit growth, largely driven by the Marcum acquisition.

CBIZ has posted remarkably strong financial results for Q2 2025, with total revenue surging 62.7% to $683.5 million compared to the same period last year. This impressive top-line growth was accompanied by even stronger bottom-line performance, with net income more than doubling to $41.9 million, representing a 111.9% increase year-over-year.

The company's adjusted EBITDA showed exceptional improvement, reaching $117.2 million - a dramatic 127.9% increase from Q2 2024. Similarly, adjusted EPS of $0.95 represents a 63.8% growth compared to the previous year.

These results underscore the transformative impact of CBIZ's acquisition of Marcum, which management described as "among the most important and value-creating strategic decisions in our history." The integration appears to be progressing well, contributing significantly to the company's expanded scale and profitability.

For the first half of 2025, CBIZ maintained this strong momentum with six-month revenue of $1.5 billion (up 66.4%) and adjusted EBITDA of $355.6 million (up 108.9%). The forward guidance suggests continued confidence, with full-year revenue projected between $2.8 billion and $2.95 billion, and adjusted EBITDA expected to reach $450-456 million.

The company's business model appears particularly resilient during challenging market conditions, supported by a high proportion of essential, recurring services, strong client retention, robust free cash flow, and disciplined cost management. These fundamentals, combined with the successful integration of Marcum, position CBIZ well for sustained growth and improved profitability.

SECOND-QUARTER HIGHLIGHTS:

  • TOTAL REVENUE OF $683.5M, UP 62.7%
  • NET INCOME OF $41.9M, UP 111.9%; GAAP EPS OF $0.66, UP 69.2%;
  • ADJUSTED EBITDA OF $117.2M, UP 127.9%; ADJUSTED DILUTED EPS OF $0.95, UP 63.8%

SIX-MONTH HIGHLIGHTS:

  • TOTAL REVENUE OF $1.5B, UP 66.4%
  • NET INCOME OF $164.7M, UP 70.4%; GAAP EPS OF $2.58, UP 34.4%;
  • ADJUSTED EBITDA OF $355.6M, UP 108.9%; ADJUSTED DILUTED EPS OF $3.26, UP 46.8%

CLEVELAND, July 30, 2025 (GLOBE NEWSWIRE) -- CBIZ, Inc., (NYSE: CBZ) (“CBIZ� or the “Company�), a leading national professional services advisor, today announced results for the second quarter ended June30, 2025.

“We’re pleased to deliver strong earnings in the second quarter and year-to-date demonstrating the strength and resilience of our business model amidst challenging market conditions,� said Jerry Grisko, CBIZ President and CEO.

“This has been a monumental time for our business, our clients, our industry and especially our team members with the Marcum acquisition being among the most important and value-creating strategic decisions in our history. With a high proportion of essential, recurring services, strong client retention, robust free cash flow, and disciplined cost management, we’re well-positioned for future growth.�

For the second quarter of 2025, CBIZ recorded revenue of $683.5 million, an increase of $263.5 million, or 62.7%, compared with $420.0 millionreported for the same period in 2024. Net income was $41.9 million, or $0.66 per diluted share, for the second quarter of 2025, compared with $19.8 million, or $0.39 per diluted share, for the same period a year ago.

Excluding acquisition-related integration expenses, amortization of intangible assets, and other non-recurring gains and losses, Adjusted net income was $60.5 million in the second quarter of 2025, compared with Adjusted net income of $29.5 million for the same period a year ago. Adjusted earnings per share were $0.95 for the second quarter of 2025, an increase of 63.8%, compared with Adjusted earnings per share of $0.58 for the same period a year ago. Adjusted EBITDA for the second quarter of 2025 was $117.2 million, up 127.9%, compared with $51.4 million for the same period in 2024.

For the six months ended June 30, 2025, CBIZ recorded revenue of $1,521.5 million, an increase of $607.2 million or 66.4%, over the $914.3 million recorded for the same period in 2024. Net income was $164.7 million, or $2.58 per diluted share, for the six months ended June 30, 2025, compared with $96.7 million, or $1.92 per diluted share, for the same period a year ago.

For the six months ended June 30, 2025, Adjusted net income was $208.4 million, compared with Adjusted net income of $111.7 million for the same period a year ago. Adjusted earnings per share was $3.26 for the six months ended June 30, 2025, an increase of 46.8%, compared with Adjusted earnings per share of $2.22 for the same period a year ago. Adjusted EBITDA for the six months ended June 30, 2025, was $355.6 million, compared with $170.2 million for the same period in 2024.

2025 Outlook

The Company expects:

  • Total revenue within a range of $2.8 billion to $2.95 billion
  • Effective tax rate of approximately 29%
  • Weighted average fully diluted share count within a range of 64.5 to 65.0 million shares
  • GAAP fully diluted earnings per share to be within a range of $1.97 to $2.02
  • Adjusted fully diluted earnings per share within a range of $3.60 to $3.65
  • Adjusted EBITDA within a range of $450 million to $456 million

Conference Call

CBIZ will host a conference call today at 5 p.m. (ET) to discuss its second-quarter financial results. The call will be webcast, and an archived replay will be available at . Participants can register for the conference call at .

About CBIZ

CBIZ, Inc. (NYSE: CBZ) is a leading professional services advisor to middle-market businesses nationwide. With industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers actionable insights to help clients anticipate what is next and discover new ways to accelerate growth. CBIZ has more than 10,000 team members across more than 160 locations in 22 major markets coast to coast. For more information, visit .

Forward-Looking Statements

This release contains “forward-looking statements� within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act�), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act�). All statements other than statements of historical fact included in this release, including, without limitation, our �2025 Outlook,� regarding our financial position, business strategy and plans and objectives for future performance are forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are commonly identified by the use of such terms and phrases as “will,� “could,� “can,� “may,� “strive,� “hope,� “intend,� “believe,� “estimate,� “continue,� “plan,� “expect,� “project,� “anticipate,� “outlook,� “foreseeable future,� “seek� and words or phrases of similar import in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated services, sales efforts, expenses, and financial results.

From time to time, we may also provide oral or written forward-looking statements in other materials we release to the public. Any or all of our forward-looking statements in this release and in any other public statements that we make, are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to: payments on accounts receivable may be slower than expected, or amounts due on receivables or notes may not be fully collectible; our business could be adversely affected if Marcum does not perform to our expectations or we underestimate the liabilities we have assumed; we are dependent on the services of our executive officers, and other key employees, the loss of whom may have a material adverse effect on our business, financial condition and results of operations; restrictions imposed by independence requirements and conflict of interest rules, as well as the nature and terms of our current administrative service agreements, limit our ability to provide services to clients of the attest firms with which we have contractual relationships and the ability of such attest firms to provide attestation services to our clients; our goodwill and other intangible assets could become impaired, which could lead to material non-cash charges against earnings and a material impact on our results of operations and financial condition; certain liabilities resulting from acquisitions are estimated and could lead to a material impact on our results of operations; we may fail to realize the anticipated benefits of acquisitions, or they may prove disruptive and could result in the combined business failing to meet our expectations; recent Securities & Exchange Commission ("SEC") and Public Company Accounting Oversight Board sanctions against Marcum may adversely impact our performance and reputation; if we are unable to implement and maintain effective internal control over financial reporting following the acquisition of Marcum (the Transaction), we may fail to prevent or detect material misstatements in our financial statements, in which case investors could lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may decline; we may not be able to acquire and finance additional businesses, which could limit our ability to pursue our business strategy; we will incur transaction, integration, and restructuring costs in connection with our acquisition program; governmental regulations and interpretations are subject to changes, which could have a material adverse effect on our financial condition; changes in the United States healthcare environment, including new healthcare legislation, may adversely affect the revenue and margins in our healthcare benefit business; we are subject to risks relating to processing customer transactions for our payroll and other transaction processing businesses; cyberattacks or other security breaches involving our computer systems or the systems of one or more of our vendors could materially and adversely affect our business; we are subject to risk as it relates to software that we license from third parties; we are reliant on information processing systems and any failure or disruptions of these systems could have a material adverse effect on our business, financial condition and results of operations; we could be held liable for errors and omissions; the business services industry is competitive and fragmented, if we are unable to compete effectively, our business, financial condition and results of operations could be negatively impacted; given our levels of share-based compensation, our tax rate may vary significantly depending on our stock price; rapid technological changes could significantly impact our competitive position, client relationships and operating results and our ability to realize the anticipated benefits of the Transaction; climate change legislation or regulations restricting emissions of greenhouse gases could result in increased operating costs; the widespread outbreak of a communicable illness or any other public health crisis could adversely affect our business, financial condition and results of operations; we require a significant amount of cash for interest payments on our debt and to expand our business as planned; terms of our amended and restated credit agreement providing for $2.0 billion in senior secured credit facilities, consisting of a $1.4 billion term loan and $600.0 million revolving credit facility, could adversely affect our ability to run our business and/or reduce stockholder returns; our failure to satisfy covenants in our debt instruments could cause a default under those instruments; our increased leverage following the Transaction may adversely impact our business; we may be more sensitive to revenue fluctuations than other companies, which could result in fluctuations in the market price of our common stock; the significant number of shares issuable as the stock consideration in the Transaction may adversely impact our stock price; the future issuance of additional shares could adversely affect the price of our common stock; there is volatility in our stock price; and the price of our common stock could be adversely impacted if we do not perform to expectations following the Transaction.

Such forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Should one or more of these risks materialize, or should the underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated, projected or implied.

Consequently, no forward-looking statement can be guaranteed. A more detailed description of risk factors may be found in our periodic filings with the SEC, including in “Item 1A. Risk Factors� of our Annual Report on Form 10-K for the year ended December 31, 2024. All forward-looking statements made in this release are made only as of the date hereof, and we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are advised, however, to consult any further disclosures we make on related subjects in the current, quarterly, periodic and annual reports we file with the SEC.

Non-GAAP Financial Measures

To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we also present Adjusted Net Income (Loss), Adjusted Diluted Earnings Per Share (“EPS�), and Adjusted EBITDA, which are non-GAAP measures. These non-GAAP measures are adjusted to exclude the impact of the Transaction, integration costs, amortization of acquired intangible assets, and other significant non-operating related gains and losses management does not consider ongoing in nature.

The presentation of non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use these non-GAAP financial measures for financial and operational decision-making, and to evaluate results relative to employee compensation targets. We believe that these non-GAAP financial measures provide meaningful supplemental information to stockholders, debt holders, and other interested parties in assessing our performance. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance by excluding significant acquisition expenses, certain one-time non-recurring items, and gains and losses that management does not consider ongoing in nature. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key measures used by management in its financial and operational decision-making and (2) they are used by our stockholders and analyst community to determine the health of our business.

Management provides specific information regarding the GAAP amounts excluded from or included in these non-GAAP financial measures. Additionally, management provides reconciliations of these non-GAAP financial measures to their most comparable financial measures in accordance with GAAP. Please see the sections captioned “GAAP Reconciliation� within the Appendix for the reconciliations.

CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
THREE MONTHS ENDED JUNE 30, 2025 AND 2024
(In thousands, except percentages and per share data)
Three Months Ended June 30,
2025%2024%
Revenue$683,496100.0%$420,012100.0%
Operating expenses(1)595,58787.1366,36887.2
Gross margin87,90912.953,64412.8
Corporate general and administrative expenses(1)27,6374.022,0505.2
Operating income60,2728.931,5947.6
Other (expense) income:
Interest expense(27,867)(4.1)(5,884)(1.4)
Other income, net(1) (2)25,3743.72,4830.6
Total other expense, net(2,493)(0.4)(3,401)(0.8)
Income before income tax expense57,7798.528,1936.8
Income tax expense15,8378,400
Net income$41,9426.1%$19,7934.7%
Diluted earnings per share$0.66$0.39
Diluted weighted average common shares outstanding63,78450,276
Other data:
Adjusted EBITDA(3)$117,15317.1%$51,40612.2%
Adjusted Diluted EPS(3)$0.95$0.58


(1)CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other income (expense), net." The deferred compensation plan has no impact on "Income before income tax expense."
Income and expenses related to the deferred compensation plan for the three months ended June30, 2025, and 2024, are as follows (in thousands, except percentages):


Three Months Ended June 30,
2025
% of Revenue2024
% of Revenue
Operating expenses$11,7171.7%$2,2830.5%
Corporate general & administrative expenses1,4580.2%3230.1%
Other income, net13,1751.9%2,6060.6%


Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the three months ended June30, 2025, and 2024, are as follows (in thousands, except percentages):


Three Months Ended June 30,
20252024
As ReportedDeferred Compensation PlanAdjusted% of RevenueAs ReportedDeferred Compensation PlanAdjusted% of Revenue
Gross margin$87,909$11,717$99,62614.6%$53,644$2,283$55,92713.3%
Operating income60,27213,17573,44710.7%31,5942,60634,2008.1%
Other income, net25,374(13,175)12,1991.8%2,483(2,606)(123)%
Income before income tax expense57,77957,7798.5%28,19328,1936.8%


(2)Included in "Other income, net" for the three months ended June30, 2025, and 2024, is expense of $1.0 million and $0.2 million, respectively, related to net changes in the fair value of contingent consideration related to CBIZ's prior acquisitions. Additionally, during the three months ended June 30, 2025 the Company recorded a $12.5 million gain from a legal settlement.
(3)Refer to the schedules reconciling Adjusted Diluted EPS and Adjusted EBITDA to the most directly comparable GAAP financial measures at the end of this release, and for additional information as to the usefulness of the non-GAAP financial measures to stockholders and investors.


CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
SIX MONTHS ENDED JUNE 30, 2025 AND 2024
(In thousands, except percentages and per share data)
Six Months Ended June 30,
2025%2024%
Revenue$1,521,510100.0%$914,309100.0%
Operating expenses(1)1,205,49979.2742,85381.2
Gross margin316,01120.8171,45618.8
Corporate general and administrative expenses(1)55,7073.740,7614.5
Operating income260,30417.1130,69514.3
Other (expense) income:
Interest expense(53,023)(3.5)(10,395)(1.1)
Other income, net(1) (2)23,4081.511,9071.3
Total other (expense) income, net(29,615)(2.0)1,5120.2
Income before income tax expense230,68915.1132,20714.5
Income tax expense65,97435,530
Net income$164,71510.8%$96,67710.6%
Diluted earnings per share$2.58$1.92
Diluted weighted average common shares outstanding63,96050,248
Other data:
Adjusted EBITDA(3)$355,56923.4%$170,23618.6%
Adjusted EPS(3)$3.26$2.22


(1)CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other income (expense), net." The deferred compensation plan has no impact on "Income before income tax expense."
Income and expenses related to the deferred compensation plan for the six months ended June30, 2025, and 2024, are as follows (in thousands, except percentages):


Six Months Ended June 30,
2025
% of Revenue2024
% of Revenue
Operating expenses$9,2850.6%$10,8591.2%
Corporate general and administrative expenses1,3390.1%1,3800.2%
Other income, net10,6240.7%12,2391.3%


Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the six months ended June30, 2025, and 2024, are as follows (in thousands, except percentages):


Six Months Ended June 30,
20252024
As ReportedDeferred Compensation PlanAdjusted% of RevenueAs ReportedDeferred Compensation PlanAdjusted% of Revenue
Gross margin$316,011$9,285$325,29621.4%$171,456$10,859$182,31519.9%
Operating income260,30410,624270,92817.8%130,69512,239142,93415.6%
Other income, net23,408(10,624)12,7840.8%11,907(12,239)(332)%
Income before income tax expense230,689230,68915.2%132,207132,20714.5%


(2)Included in "Other income, net" for the six months ended June30, 2025, and 2024, is expense of $1.5 million and $0.6 million, respectively, related to net changes in the fair value of contingent consideration related to CBIZ's prior acquisitions. Additionally, during the six months ended June 30, 2025 the Company recorded a $12.5 million gain from a legal settlement.
(3)Refer to the schedules reconciling Adjusted earnings per share and Adjusted EBITDA to the most directly comparable GAAP financial measures at the end of this release and for additional information as to the usefulness of the non-GAAP financial measures to stockholders and investors.


CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
SELECT SEGMENT DATA
(In thousands)
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Revenue
Financial Services$569,819$309,233$1,283,480$681,863
Benefits and Insurance Services101,92997,419214,905205,827
National Practices11,74813,36023,12526,619
Total Revenue$683,496$420,012$1,521,510$914,309
Gross Margin
Financial Services$85,361$46,424$288,529$153,493
Benefits and Insurance Services17,92214,17645,54038,947
National Practices1,2671,3322,3792,658
Operating expenses - unallocated(1):
Other expense(4,924)(6,005)(11,152)(12,783)
Deferred compensation(11,717)(2,283)(9,285)(10,859)
Total Gross Margin$87,909$53,644$316,011$171,456
As a % of Revenue12.9%12.8%20.8%18.8%


(1)Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, consolidation and integration charges, and certain advertising expenses. "Operating expenses - unallocated" also includes gains or losses attributable to the assets held in a rabbi trust associated with the Company's deferred compensation plan. These gains or losses do not impact "Income before income tax expense" as they are directly offset by the same adjustment to "Other income (expense), net" in the Consolidated Statements of Comprehensive Income. Net gains or losses recognized from adjustments to the fair value of the assets held in the rabbi trust are recorded as compensation expense (income) in "Operating expenses" and “Corporate, general and administrative expenses,� and offset in "Other income (expense), net."


CBIZ, INC.
SELECT CASH FLOW DATA (UNAUDITED)
(In thousands)
Six Months Ended June 30,
20252024
Net income$164,715$96,677
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense49,85819,008
Bad debt expense, net of recoveries1,8621,244
Adjustments to contingent earnout liability, net1,487638
Stock-based compensation expense12,2395,016
Other noncash adjustments19,8313,401
Net income, after adjustments to reconcile net income to net cash provided by operating activities249,992125,984
Changes in assets and liabilities, net of acquisitions and divestitures(225,112)(101,545)
Net cash provided by operating activities24,88024,439
Net cash used in investing activities(12,299)(33,247)
Net cash used in financing activities(33,249)(11,920)
Net decrease in cash, cash equivalents and restricted cash(20,668)(20,728)
Cash, cash equivalents and restricted cash at beginning of year$187,170$157,148
Cash, cash equivalents and restricted cash at end of period$166,502$136,420
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:
Cash and cash equivalents$39,817$1,128
Restricted cash49,14544,947
Cash equivalents included in funds held for clients77,54090,345
Total cash, cash equivalents and restricted cash$166,502$136,420


CBIZ, INC.
SELECT FINANCIAL DATA AND RATIOS (UNAUDITED)
(In thousands, except percentages, DSO, and per share data)
June 30, 2025December 31, 2024
Cash and cash equivalents$39,817$13,826
Restricted cash49,14538,661
Accounts receivable, net676,054534,858
Other current assets82,14272,528
Current assets before funds held for clients847,158659,873
Funds held for clients118,877175,853
Goodwill and other intangible assets, net2,899,9582,945,470
Total assets4,537,9734,470,883
Current liabilities before client fund obligations, excluding short-term debt417,342463,697
Client fund obligations118,705175,928
Total short-term debt, net66,27466,177
Total long-term debt, net1,488,2151,333,755
Total liabilities2,646,1302,690,900
Treasury stock(989,680)(910,601)
Total stockholders' equity1,891,8431,779,983
Debt to equity82.2%78.6%
Days sales outstanding (DSO)(1)8773
Shares outstanding54,02450,198
Basic weighted average common shares outstanding63,54252,375
Diluted weighted average common shares outstanding63,78452,661


(1)DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing twelve-months daily revenue. The Company has included DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of the Company's ability to collect on receivables in a timely manner. DSO should not be regarded as an alternative or replacement to any measurement of performance under GAAP. DSO on June30, 2024, was 95.


CBIZ, INC.
GAAP RECONCILIATION
Net Income (Loss) and Diluted Earnings Per Share (“EPS�) to Adjusted Net Income (Loss), Adjusted Diluted EPS and Adjusted EBITDA(1)
(Unaudited. Amounts in thousands, except per share data)
Three Months Ended June 30, 2025
Financial ServicesBenefits and Insurance ServicesNational PracticesCorporate & OtherConsolidatedEPS
Net income (loss)$85,335$17,968$1,267$(62,628)$41,942$0.66
Adjustments:
Integration costs related to acquisitions(2)4,98722613,95019,1630.31
Amortization of acquired intangible assets17,0911,69918,7900.29
Litigation gain, net(3)(11,859)(11,859)(0.19)
Income tax effect related to adjustments(7,552)(7,552)(0.12)
Adjusted net income (loss)$107,413$19,893$1,267$(68,089)$60,484$0.95
Interest expense27,86727,867
Income tax expense15,83715,837
Tax effect related to the adjustments above7,5527,552
Depreciation(4)3,78953421,0885,413
Adjusted EBITDA$111,202$20,427$1,269$(15,745)$117,153
As a % of Revenue19.5%20.0%10.8%N/A17.1%
Three Months Ended June 30, 2024
Financial ServicesBenefits and Insurance ServicesNational PracticesCorporate & OtherConsolidatedEPS
Net income (loss)$46,552$14,219$1,328$(42,306)$19,793$0.39
Adjustments:
Integration costs related to acquisitions(2)1621696,6506,9810.14
Amortization of acquired intangible assets4,0211,9996,0200.12
Facility optimization costs(5)8585
Litigation cost(3)7237230.01
Income tax effect related to adjustments(4,114)(4,114)(0.08)
Adjusted net income (loss)$50,735$16,387$1,328$(38,962)$29,488$0.58
Interest expense5,8845,884
Income tax expense8,4008,400
Tax effect related to the adjustments above4,1144,114
Depreciation1,78455891,1693,520
Adjusted EBITDA$52,519$16,945$1,337$(19,395)$51,406
As a % of Revenue17.0%17.4%10.0%N/A12.2%


(1)This table reconciles Adjusted net income (loss), Adjusted diluted EPS, and Adjusted EBITDA to the most directly comparable GAAP financial measures. Adjusted net income (loss), Adjusted diluted EPS, and Adjusted EBITDA exclude the impact of Marcum acquisition and other significant non-operating related gains and losses that management does not consider on-going in nature. Please refer to the 'Non-GAAP Financial Measures' section for further management discussion.
(2)These costs include, but are not limited to, certain consulting, technology, personnel, as well as other integration costs related to acquisitions. Amounts reported for 2025 relate to the costs associated with the acquisition of Marcum, and amounts reported in 2024 relate to the costs associated with the acquisitions of Erickson, Brown & Kloster, LLC and CompuData, Inc.
(3)During the three months ended June 30, 2025, the Company recorded a gain of $12.5 million related to a legal settlement payment from a small group of former employees. The gain was recorded in “other income (expense), net� on the consolidated statement of comprehensive income. The costs associated with this litigation were $0.6 million and $0.7 million, respectively, for the three months ended June 30, 2025 and 2024, and were recorded in “Corporate general and administrative expenses� on the consolidated statement of comprehensive income.
(4)Depreciation expense reported for 2025 excluded $0.9 million of depreciation expense reported as “Integration costs related to acquisitions� above. The accelerated depreciation was associated with certain technology assets from the acquisition of Marcum.
(5)These costs related to incremental non-recurring lease expenses incurred as a result of CBIZ's real estate optimization efforts.


Six months ended June 30, 2025
Financial ServicesBenefits and Insurance ServicesNational PracticesCorporate & OtherConsolidatedEPS
Net income (loss)$288,688$45,913$2,379$(172,265)$164,715$2.58
Adjustments:
Integration costs related to acquisitions(2)7,50038126,97434,8550.54
Amortization of acquired intangible assets33,9813,47537,4560.59
Litigation gain, net(3)(11,063)(11,063)(0.17)
Income tax effect related to adjustments(17,516)(17,516)(0.28)
Adjusted net income (loss)$330,169$49,769$2,379$(173,870)$208,447$3.26
Interest expense53,02353,023
Income tax expense65,97465,974
Tax effect related to the adjustments above17,51617,516
Depreciation(4)7,3461,08332,17710,609
Adjusted EBITDA$337,515$50,852$2,382$(35,180)$355,569
As a % of Revenue26.3%23.7%10.3%N/A23.4%
Six months ended June 30, 2024
Financial ServicesBenefits and Insurance ServicesNational PracticesCorporate & OtherConsolidatedEPS
Net income (loss)$153,707$39,034$2,654$(98,718)$96,677$1.92
Adjustments:
Integration costs related to acquisitions(2)2571697,1377,5630.15
Amortization of acquired intangible assets7,9164,048111,9650.24
Facility optimization costs(5)3403400.01
Litigation cost(3)7237230.01
Income tax effect related to adjustments(5,534)(5,534)(0.11)
Adjusted net income (loss)$161,880$43,251$2,654$(96,051)$111,734$2.22
Interest expense10,39510,395
Income tax expense35,53035,530
Tax effect related to the adjustments above5,5345,534
Depreciation3,5811,148182,2967,043
Adjusted EBITDA$165,461$44,399$2,672$(42,296)170,236
As a % of Revenue24.3%21.6%10.0%N/A18.6%


(1)This table reconciles Adjusted net income (loss), Adjusted diluted EPS, and Adjusted EBITDA to the most directly comparable GAAP financial measures. Adjusted net income (loss), Adjusted diluted EPS, and Adjusted EBITDA exclude the impact of Marcum acquisition and other significant non-operating related gains and losses that management does not consider on-going in nature. Please refer to the 'Non-GAAP Financial Measures' section for further management discussion.
(2)These costs include, but are not limited to, certain consulting, technology, personnel, as well as other integration costs related to acquisitions. Amounts reported for 2025 relate to the costs associated with the acquisition of Marcum, and amounts reported in 2024 relate to the costs associated with the acquisitions of Erickson, Brown & Kloster, LLC and CompuData, Inc.
(3)During the six months ended June 30, 2025, the Company recorded a gain of $12.5 million related to a legal settlement payment from a small group of former employees. The gain was recorded in “other income (expense), net� on the consolidated statement of comprehensive income for the six months ended June 30, 2025. The costs associated with this litigation were $1.4 million and $0.7 million, respectively, for the six months ended June 30, 2025 and 2024, and were recorded in “Corporate general and administrative expenses� on the consolidated statement of comprehensive income.
(4)Depreciation expense reported for 2025 excluded $1.8 million of depreciation expense reported as “Integration costs related to acquisitions� above. The accelerated depreciation was associated with certain technology assets from the acquisition of Marcum.
(5)These costs related to incremental non-recurring lease expenses incurred as a result of CBIZ's real estate optimization efforts.


CBIZ, INC.
GAAP RECONCILIATION
Full Year 2025 Net Income and Diluted Earnings Per Share (“EPS�) to Adjusted Net Income, Adjusted Diluted EPS, and Adjusted EBITDA Guidance
Full Year 2025 Guidance
(Amounts in millions except per share data)
LowHigh
AmountsEPSAmountsEPS
GAAP Net Income$127.9$1.97$131.1$2.02
Amortization of acquired intangible assets(1)75.11.1575.11.15
Integration costs related to acquisitions(2)75.01.1575.01.15
Income tax effect related to adjustments(43.5)(0.67)(43.5)(0.67)
Adjusted Net Income$234.5$3.60$237.7$3.65
Depreciation22.122.1
Interest expense99.399.3
Income tax expense included the tax effect related to the adjustments above94.597.1
Adjusted EBITDA$450.4$456.2


(1)These costs represent the amortization of the intangible assets, such as client lists, recognized as a result of applying Accounting Standards Codification Topic 850, Business Combinations. The amount of amortization expense recorded in each period is significantly affected by the size and timing of our acquisitions.
(2)These costs include, but are not limited to, certain consulting, technology, personnel, as well as other operating and general administrative costs associated with the integration of the Marcum business.

Contacts:

Media: Amy McGahan, Director of Corporate & Strategic Communications,
Investor Relations: Lori Novickis, Director, Corporate Relations,
CBIZ, Inc., Cleveland, Ohio, (216) 447-9000


FAQ

What were CBIZ's Q2 2025 earnings results?

CBIZ reported Q2 2025 revenue of $683.5 million, up 62.7% year-over-year, with net income of $41.9 million and adjusted EPS of $0.95, up 63.8%.

What is CBIZ's revenue guidance for 2025?

CBIZ expects total revenue for 2025 to be between $2.8 billion and $2.95 billion, with adjusted EBITDA ranging from $450 million to $456 million.

How did the Marcum acquisition impact CBIZ's performance?

The Marcum acquisition was described as one of the most important and value-creating strategic decisions in CBIZ's history, contributing to the significant revenue and earnings growth in Q2 2025.

What was CBIZ's adjusted EBITDA for Q2 2025?

CBIZ's adjusted EBITDA for Q2 2025 was $117.2 million, representing a 127.9% increase compared to $51.4 million in Q2 2024.

What is CBIZ's earnings per share outlook for 2025?

CBIZ projects GAAP fully diluted EPS of $1.97 to $2.02 and adjusted fully diluted EPS of $3.60 to $3.65 for 2025.
Cbiz Inc

NYSE:CBZ

CBZ Rankings

CBZ Latest News

CBZ Latest SEC Filings

CBZ Stock Data

3.33B
48.56M
10.08%
85.87%
5.36%
Specialty Business Services
Services-business Services, Nec
United States
INDEPENDENCE